Learn / ALLO
NASDAQ: ALLO
Allogene Therapeutics (ALLO) stock, explained like you're 5
Allogene Therapeutics trades on the Nasdaq under the ticker ALLO. It is a small cap company in the biological products (no diagnostic substances) industry, part of the healthcare sector, with a market value of about 504 million dollars.
- Ticker
- ALLO
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Biological Products (No Diagnostic Substances)
- Size
- Small cap, about 504 million dollars
Is Allogene Therapeutics a small, medium or large cap company?
No. Allogene Therapeutics is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 504 million dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Allogene Therapeutics makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves ALLO stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- Is Allogene Therapeutics (ALLO) Stock Outpacing Its Medical Peers This Year? (Yahoo Finance)
- Insider Sellers Might Regret Selling Allogene Therapeutics Shares at a Lower Price Than Current Market Value (Moomoo)
- ALLO Stock Soars As ALPHA3 Trial Data Reset Expectations (timothysykes.com)
- Allogene Therapeutics Announces Participation in Upcoming Investor Conferences (Allogene)
- Citizens reiterates Allogene stock rating on trial progress (Investing.com)
Follow ALLO in your daily brief
Each trading day at 5 PM ET we post what happened to Allogene Therapeutics and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow ALLO
Questions about Allogene Therapeutics stock
What does Allogene Therapeutics do?
Allogene Therapeutics trades on the Nasdaq under the ticker ALLO. It is a small cap company in the biological products (no diagnostic substances) industry, part of the healthcare sector, with a market value of about 504 million dollars.
What is the ticker symbol for Allogene Therapeutics?
Allogene Therapeutics trades under the ticker ALLO on the Nasdaq.
What is Allogene Therapeutics's market cap?
Allogene Therapeutics is a small cap stock with a market cap of about 504 million dollars.
How does Allogene Therapeutics make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves ALLO stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow ALLO stock every day?
Add ALLO to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.